| Q42702771 | A translational preclinical model of interstitial pulmonary fibrosis and pulmonary hypertension: mechanistic pathways driving disease pathophysiology |
| Q37152742 | Acute exacerbations in patients with idiopathic pulmonary fibrosis |
| Q36168860 | Acute exacerbations of idiopathic pulmonary fibrosis |
| Q35163605 | Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide |
| Q37972397 | Alternative origins of stroma in normal organs and disease |
| Q33875114 | Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis |
| Q41717218 | Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity |
| Q37328738 | Associations between fibrocytes and postcontrast myocardial T1 times in hypertrophic cardiomyopathy |
| Q39206288 | Blood Biomarkers in Idiopathic Pulmonary Fibrosis |
| Q33799560 | Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-α-induced pulmonary fibrosis |
| Q37394389 | CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes |
| Q35108148 | CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in rats |
| Q64253973 | CXCR4-Overexpressing Umbilical Cord Mesenchymal Stem Cells Enhance Protection against Radiation-Induced Lung Injury |
| Q33579016 | Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis |
| Q34154288 | Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease |
| Q36093857 | Caveolin-1 signaling in lung fibrosis |
| Q34387011 | Circulating fibrocytes and Crohn's disease. |
| Q30362039 | Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. |
| Q56480036 | Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease |
| Q30277093 | Circulating fibrocytes as predictors of adverse events in unstable angina |
| Q30425688 | Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker |
| Q42154997 | Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. |
| Q33989134 | Circulating progenitor cells and scleroderma |
| Q30426894 | Circulating progenitor cells in chronic lung disease |
| Q53180514 | Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases. |
| Q36822323 | Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function |
| Q34250211 | Decreased fibrocyte number is associated with atherosclerotic plaque instability in man. |
| Q37594222 | Determinants of initiation and progression of idiopathic pulmonary fibrosis |
| Q37341340 | Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer. |
| Q42575931 | Differentiation of circulating monocytes into fibroblast-like cells. |
| Q55105794 | Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation. |
| Q30419423 | Elevated circulating fibrocyte levels in patients with hypertensive heart disease |
| Q37846143 | Epithelial-mesenchymal interactions in biliary diseases |
| Q51445201 | Epithelial-mesenchymal transition contributes to SWCNT-induced pulmonary fibrosis. |
| Q43180245 | Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis |
| Q43035229 | Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF). |
| Q54446707 | Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis. |
| Q33837137 | Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE. |
| Q36232242 | FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation |
| Q34793502 | Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis |
| Q30435304 | Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis |
| Q34019284 | Fibrocyte activation in rheumatoid arthritis |
| Q28390280 | Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease |
| Q30426516 | Fibrocytes and the pathogenesis of diffuse parenchymal lung disease |
| Q47705165 | Fibrocytes are involved in inflammation as well as fibrosis in the pathogenesis of Crohn's disease |
| Q28085703 | Fibrocytes at 20 Years |
| Q83371739 | Fibrocytes in health and disease |
| Q37158258 | Fibrocytes in the Pathogenesis of Chronic Fibrotic Lung Disease. |
| Q89613159 | Fibrocytes in the Tumor Microenvironment |
| Q30432829 | Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis |
| Q39634075 | Fibrocytes: emerging effector cells in chronic inflammation |
| Q36690680 | Fibrocytes: emerging effector cells in chronic inflammation |
| Q33799756 | Following the path of CCL2 from prostaglandins to periostin in lung fibrosis |
| Q28076273 | From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling |
| Q41855879 | Functional KCa3.1 K+ channels are required for human fibrocyte migration |
| Q34804461 | HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic |
| Q37845721 | Hematopoietic stem cell homing to injured tissues. |
| Q38183378 | Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis |
| Q55143948 | Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis. |
| Q26852800 | Host responses in tissue repair and fibrosis |
| Q30432500 | Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes |
| Q86095812 | IL-17A/F modulates fibrocyte functions in cooperation with CD40-mediated signaling |
| Q39079208 | IL-33 enhanced the proliferation and constitutive production of IL-13 and IL-5 by fibrocytes |
| Q37788591 | Idiopathic Pulmonary Fibrosis—an Epidemiological and Pathological Review |
| Q34380533 | Improved serum-free culture conditions for spleen-derived murine fibrocytes |
| Q41904647 | Improved serum-free culture conditions for the differentiation of human and murine fibrocytes. |
| Q50138861 | Inclusion of the mesentery in ileocolic resection for Crohn's disease is associated with reduced surgical recurrence |
| Q41439207 | Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemia |
| Q33586738 | Increased generation of fibrocytes in thyroid-associated ophthalmopathy |
| Q34951145 | Increased serum oxidative stress markers in women with uterine leiomyoma |
| Q33911638 | Inhibition of murine fibrocyte differentiation by cross-linked IgG is dependent on FcγRI |
| Q35132609 | Inhibition of the CXCL12/CXCR4 chemokine axis with AMD3100, a CXCR4 small molecule inhibitor, worsens murine hepatic injury |
| Q33942836 | Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis |
| Q93089254 | Insulin-like growth factor binding protein-4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C-X-C chemokine receptor 4 |
| Q41640757 | Intersection of Chemokine and TSH Receptor Pathways in Human Fibrocytes: Emergence of CXCL-12/CXCR4 Cross Talk Potentially Relevant to Thyroid-Associated Ophthalmopathy |
| Q30398970 | Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments. |
| Q35068120 | Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor β1-induced lung fibrosis |
| Q51418425 | MEKK1, JNK, and SMAD3 mediate CXCL12-stimulated connective tissue growth factor expression in human lung fibroblasts. |
| Q90002285 | Megakaryocytes participate in the occurrence of bleomycin-induced pulmonary fibrosis |
| Q47123592 | Mesenchymal stem cells in idiopathic pulmonary fibrosis |
| Q47566394 | Mesenchymal stem cells: A double-edged sword in radiation-induced lung injury |
| Q37358577 | Microvascular targets for anti-fibrotic therapeutics |
| Q40515227 | Myeloid-derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in chronic obstructive pulmonary disease. |
| Q30434264 | New mechanisms of pulmonary fibrosis |
| Q38180825 | Paracrine functions of fibrocytes to promote lung fibrosis |
| Q33976506 | Pathogenesis of idiopathic pulmonary fibrosis |
| Q35138521 | Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-/-) knockout mice |
| Q37137667 | Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. |
| Q39406925 | Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden |
| Q34674982 | Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder |
| Q27321863 | Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection |
| Q27694249 | Pulmonary fibrosis: patterns and perpetrators |
| Q27309062 | Pulmonary vaccination as a novel treatment for lung fibrosis |
| Q42368982 | R1R2 peptide ameliorates pulmonary fibrosis in mice through fibrocyte migration and differentiation |
| Q30409683 | Rapamycin blocks fibrocyte migration and attenuates bronchiolitis obliterans in a murine model |
| Q36298255 | Rapid detection of circulating fibrocytes by flowcytometry in idiopathic pulmonary fibrosis |
| Q34494156 | Reactive response of fibrocytes to vocal fold mucosal injury in rat |
| Q24624887 | Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3 |
| Q36705598 | Role of Circulating Fibrocytes in Cardiac Fibrosis |
| Q35219868 | Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein |
| Q51720099 | Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis. |
| Q42061983 | Role of semaphorin 7a signaling in transforming growth factor β1-induced lung fibrosis and scleroderma-related interstitial lung disease |
| Q30411470 | Short-course rapamycin treatment preserves airway epithelium and protects against bronchiolitis obliterans |
| Q37897102 | Stem cell-based therapy and regenerative approaches to diseases of the respiratory system |
| Q84303950 | Stem cells and cell therapies in lung biology and lung diseases |
| Q30486086 | Stem cells and cell therapies in lung biology and lung diseases |
| Q34361245 | Stem cells and cell therapy approaches in lung biology and diseases |
| Q93042634 | Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy |
| Q35606977 | TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis |
| Q36103058 | TNF-α-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation |
| Q35667567 | TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist |
| Q59136382 | The Development of Serum Amyloid P as a Possible Therapeutic |
| Q55208808 | The Role of Stem Cells in Dupuytren's Disease: A Review. |
| Q89909282 | The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity |
| Q40024041 | The diagnosis of idiopathic pulmonary fibrosis and its complications |
| Q55046775 | The diversity of myeloid immune cells shaping wound repair and fibrosis in the lung. |
| Q35182082 | The long pentraxin PTX3 promotes fibrocyte differentiation |
| Q28392176 | The role of RhoA and cytoskeleton in myofibroblast transformation in hyperoxic lung fibrosis |
| Q30426900 | The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders |
| Q37415507 | The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis |
| Q30438538 | The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. |
| Q30433418 | The role of fibrocytes in fibrotic diseases of the lungs and heart |
| Q30427773 | The role of fibrocytes in sickle cell lung disease |
| Q34645189 | The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. |
| Q36865803 | Vaccinia vaccine-based immunotherapy arrests and reverses established pulmonary fibrosis. |
| Q38099709 | Vascular repair and regeneration as a therapeutic target for pulmonary arterial hypertension |
| Q30439833 | What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis |
| Q28603445 | Workshop on idiopathic pulmonary fibrosis in older adults |